SAN JOSE, CA--(Marketwired - Dec 3, 2013) - Align Technology, Inc. (NASDAQ: ALGN) today announced the upcoming release of Invisalign G5 innovations, specifically designed for the treatment of deep ...

Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and ...

Offers an Innovative Treatment Option for Class II Skeletal Malocclusion in Kids and Teenage Patients While Simultaneously Straightening their Teeth The Invisalign® System with mandibular advancement ...

Align Technology, Inc. (NASDAQ: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD ...

SAN JOSE, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) announced today the launch of the ClinCheck “In-Face” Visualization tool for the Invisalign Go system, Align’s ...

Sponsorship reflects commitment to increasing access to care for orthodontic treatment especially for children, and Align’s support of the Canadian orthodontic profession Align Technology, Inc.

Align Technology’s Invisalign orthodontic system, an NFL corporate sponsor since 2020, has renewed for an additional five ...

Company’s first customized consulting service and support for digital orthodontic practice transformation As a result of the ADAPT service, on average, participating practices increased total case ...

Sponsorship of National Women’s Soccer League (NWSL) team highlights inspirational smile stories of women in sports and will help expand access to youth sports across the Bay Area SAN FRANCISCO & SAN ...

The Invisalign System with mandibular advancement featuring occlusal blocks is the latest clinical innovation that expands Align’s Class II treatment portfolio for growing patients by offering ...

Over 100 Invisalign® and iTero™-trained doctor educators from around the world spent 2 1/2 days immersed in deep-dive education workshops focused on Align’s latest innovations and clinical evidence ...